Breaking News Headlines Today

News about Merck

Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 156 stories have been published about Merck which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Pneumococcal 21-Valent Conjugate Vaccine Demonstrates Immune Response in Children 2 to <18 Years

Capvaxive was superior to PPSV23 for each of the 9 serotypes unique to Capvaxive and non inferior to PPSV23 for the 12 shared serotypes.See the Story

Susonity emerges as global pigment leader after Merck deal

GNMI acquires Merck’s Surface Solutions and rebrands as Susonity, aiming to expand globally and innovate in premium pigments for cosmetics and beyond.Merck Read Article

Merck's pneumococcal shot shows promise in at-risk children and teens

67% Center coverage: 6 sources

Merck's pneumococcal vaccine triggered immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker said on Thursday.Vaccines · United States See the Story

Merck to Supply $20M in RFID Tags in USDA Program

To strengthen national swine disease traceability, the U.S. Department of Agriculture (USDA)’s Animal and Plant Health Inspection Service (APHIS) is providing no-cost RFID eartags for sow and exhibition swine producers. Beginning this fall, eligible producers and State animal health officials will be able to order the tags through Merck Animal Health’s website. APHIS in July awarded Merck Animal Health a contract to supply up to $20 million wort…Merck · United States Read Article

Pneumococcal 21-Valent Conjugate Vaccine Demonstrates Immune Response in Children 2 to <18 Years

Capvaxive was superior to PPSV23 for each of the 9 serotypes unique to Capvaxive and non inferior to PPSV23 for the 12 shared serotypes.Merck · Lisbon See the Story

Developer To Finish Life Sciences Scheme After Merck Backs Out Of 180K SF Lab Commitment

The low-profile developer behind a major King’s Cross life sciences scheme will push on and complete the project, even after global pharmaceutical giant Merck pulled out of the building. Merck said on Thursday that it would not occupy the 180K SF Belgrove House building because the UK was “not competitive” for pharmaceutical companies due to the lower price of drugs compared to other countries. Merck's lease is still intact.Merck · London See the Story

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs - Merck & Co (NYSE:MRK)

100% Center coverage: 1 sources

Pharmaceutical companies are pulling investment from the UK as NHS drug spending falls and pricing disputes worsen.Merck · United Kingdom See the Story

UK government faces major dilemma over life sciences R&D investment - Optimum Strategic Communications

If AstraZeneca’s ditching of its plans last January for a long-expected £450 million investment in a vaccine manufacturing in Liverpool was a bright red warning sign, then Merck’s decision this week to can a half-built £1bn research centre in London is a car crash. Pharma executives have been warning the UK’s government ever since it […] The post UK government faces major dilemma over life sciences R&D investment appeared first on Optimum Strat…Merck · Liverpool Read Article

Blow for UK drugs sector as Merck scraps £1bn expansion

36% Left coverage: 25 sources

Merck manager’s awkward whispers didn’t constitute harassment, judge rules

100% Center coverage: 1 sources

The plaintiff, who spoke with a “heavy African accent,” said a manager’s comment that his voice is “very specific” was discriminatory.Merck · United States Read Article

Tata Electronics partners with Merck to boost India’s chip capabili...

Merck will offer its full suite of products and services, including high-purity electronic materials, advanced gas and chemical delivery systems, turnkey fab infrastructure services, and its Material Intelligence solutions powered by AI, for Tata Electronics’ fab in Gujarat.Merck · Gujarat Read Article

News about Merck

News about Merck

Covered Most By

Local News Publishers

Top Merck News

Blow for UK drugs sector as Merck scraps £1bn expansion

Merck's pneumococcal shot shows promise in at-risk children and teens

Pneumococcal 21-Valent Conjugate Vaccine Demonstrates Immune Response in Children 2 to <18 Years

Susonity emerges as global pigment leader after Merck deal

Merck's pneumococcal shot shows promise in at-risk children and teens

Merck to Supply $20M in RFID Tags in USDA Program

Pneumococcal 21-Valent Conjugate Vaccine Demonstrates Immune Response in Children 2 to <18 Years

Developer To Finish Life Sciences Scheme After Merck Backs Out Of 180K SF Lab Commitment

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs - Merck & Co (NYSE:MRK)

UK government faces major dilemma over life sciences R&D investment - Optimum Strategic Communications

Blow for UK drugs sector as Merck scraps £1bn expansion

Merck manager’s awkward whispers didn’t constitute harassment, judge rules

Tata Electronics partners with Merck to boost India’s chip capabili...

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Merck

Susonity emerges as global pigment leader after Merck deal

Merck's pneumococcal shot shows promise in at-risk children and teens

Merck to Supply $20M in RFID Tags in USDA Program

Pneumococcal 21-Valent Conjugate Vaccine Demonstrates Immune Response in Children 2 to <18 Years

Developer To Finish Life Sciences Scheme After Merck Backs Out Of 180K SF Lab Commitment

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs - Merck & Co (NYSE:MRK)

UK government faces major dilemma over life sciences R&D investment - Optimum Strategic Communications

Blow for UK drugs sector as Merck scraps £1bn expansion

Merck manager’s awkward whispers didn’t constitute harassment, judge rules

Tata Electronics partners with Merck to boost India’s chip capabili...